Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean L Kitson

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Radiopharmaceuticals|April 3, 2013
Articles from 2012. EditorialSean L Kitson
Current Pharmaceutical Design|September 28, 2007
5-hydroxytryptamine (5-HT) receptor ligandsSean L Kitson
Current Radiopharmaceuticals|December 15, 2015
Editorial Review 2015Sean L Kitson, Luigi Mansi
Current Radiopharmaceuticals|September 26, 2017
Editorial Review 2017Sean L Kitson, Luigi Mansi
Current Radiopharmaceuticals|April 7, 2018
PrefaceLuigi Mansi, Sean L Kitson
Current Radiopharmaceuticals|March 12, 2019
PrefaceLuigi Mansi, Sean L Kitson
Anti-Cancer Agents in Medicinal Chemistry|September 28, 2016
Targeted Therapy Towards Cancer-A PerspectiveSean L Kitson, Vincenzo Cuccurullo, Andrea Ciarmiello, et al.
Current Radiopharmaceuticals|July 2, 2013
Radionuclide antibody-conjugates, a targeted therapy towards cancerSean L Kitson, Vincenzo Cuccurullo, Thomas S Moody, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 15, 2023
Nitrilase mediated mild hydrolysis of a carbon-14 nitrile for the radiosynthesis of 4-(7-hydroxycarbamoyl-[1-<sup>14</sup> C-heptanoyl]-oxy)-benzoic acid methyl ester, [<sup>14</sup> C]-SHP-141: A novel class I/II histone deacetylase (HDAC) inhibitorSean L Kitson, William Watters, Thomas S Moody, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|June 19, 2019
Synthesis of carbon-14-labelled peptidesAntonio Dell'isola, Rodney T Brown, Stuart Jones, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Radiopharmaceuticals|April 3, 2013
Articles from 2012. EditorialSean L Kitson
Current Pharmaceutical Design|September 28, 2007
5-hydroxytryptamine (5-HT) receptor ligandsSean L Kitson
Current Radiopharmaceuticals|December 15, 2015
Editorial Review 2015Sean L Kitson, Luigi Mansi
Current Radiopharmaceuticals|September 26, 2017
Editorial Review 2017Sean L Kitson, Luigi Mansi
Current Radiopharmaceuticals|April 7, 2018
PrefaceLuigi Mansi, Sean L Kitson
Current Radiopharmaceuticals|March 12, 2019
PrefaceLuigi Mansi, Sean L Kitson
Anti-Cancer Agents in Medicinal Chemistry|September 28, 2016
Targeted Therapy Towards Cancer-A PerspectiveSean L Kitson, Vincenzo Cuccurullo, Andrea Ciarmiello, et al.
Current Radiopharmaceuticals|July 2, 2013
Radionuclide antibody-conjugates, a targeted therapy towards cancerSean L Kitson, Vincenzo Cuccurullo, Thomas S Moody, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 15, 2023
Nitrilase mediated mild hydrolysis of a carbon-14 nitrile for the radiosynthesis of 4-(7-hydroxycarbamoyl-[1-<sup>14</sup> C-heptanoyl]-oxy)-benzoic acid methyl ester, [<sup>14</sup> C]-SHP-141: A novel class I/II histone deacetylase (HDAC) inhibitorSean L Kitson, William Watters, Thomas S Moody, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|June 19, 2019
Synthesis of carbon-14-labelled peptidesAntonio Dell'isola, Rodney T Brown, Stuart Jones, et al.
Pageof 1